SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

Grayscale Bitcoin Trust (GBTC) is trending amid sharply divided community sentiment regarding Bitcoin's immediate future, with some anticipating strong bullish momentum towards new highs while others warn of an ongoing crypto winter and a significant price correction. Key discussions revolve around Bitcoin's cyclical patterns, alleged market manipulation by large players, and GBTC's competitive position given its higher expense ratio compared to newer spot Bitcoin ETFs, influencing investor decisions on holding or selling.

Bitwise 10 Crypto Index ETF - Common Shares Of Beneficial Interest

Bitwise 10 Crypto Index Fund

Bitwise 10 Crypto Index Fund (BITW) is trending due to its ongoing efforts to convert from a closed-end fund to an Exchange Traded Product (ETP), with community discussion heavily focused on the arbitrage opportunity presented by its current discount to Net Asset Value (NAV). While many anticipate this conversion will align its market price with its underlying top 10 crypto holdings, broader market sentiment remains sharply divided between those predicting a severe 'crypto winter' and those accumulating for diversified exposure.

- Maple is 'DeFi's Institutional Lender'. Maple Finance lending engine powers institutional yield for both Maple and Syrup; providing lenders with institutional quality yield overcollateralized by digital assets. The protocol combines the best of institutional lending and DeFi. Syrup is the team's newest product, offering permissionless access to Maple's lending engine whilst also integrated with the broader DeFi ecosystem including Balancer and Pendle Finance.

Syrup

SYRUP CRYPTO is actively discussed amidst its increasing accessibility on major exchanges and its positioning as a key player in the Real World Assets (RWA) and decentralized finance (DeFi) space. The community eagerly anticipates significant price growth, frequently citing its substantial Total Value Locked (TVL) and burgeoning institutional interest as indicators of its strong potential and current undervaluation.

State Street Corp. engages in the provision of financial services to institutional investors. It operates through the Commercial and Financial Loans, and Commercial Real Estate Loans segments. The company was founded in 1792 and is headquartered in Boston, MA.

State Street Corp.

State Street is trending due to significant bullish momentum, frequently hitting new highs, which is prompting active trader discussions around potential overbought conditions against a sustained upward trend. Community interest is fueled by its strategic expansions and acquisitions, alongside its pivotal role in the evolving digital asset landscape as major financial institutions embrace tokenization. This broader context, combined with recent analyst upgrades, highlights State Street's strengthening position in global financial infrastructure.

The ability to lend and borrow assets efficiently is a crucial feature of any financial system. In the world of traditional finance, this process is typically facilitated by trusted and permissioned third-parties such as banks, who connect people with a surplus of money to those who need access to it in the short term. In the world of decentralised finance (DeFi), trusted and permissioned third-parties are no longer needed; banks have been replaced by trustless and permissionless lending protocols running on the blockchain (1). Among the first-generation of DeFi lending protocols are Compound (2) and Aave (3). These protocols provide users with access to lending and borrowing capabilities for a handful of the most liquid ERC20 tokens. However, these protocols were not designed to handle the risks associated with lending and borrowing illiquid or volatile assets and have therefore relied on a permissioned listing system to protect their users from the risks associated with such assets. Consequently, there remains significant unmet demand for lending and borrowing the long tail of crypto assets. On the lending side, users want to deposit tokens to earn yield and take leveraged long positions. On the borrowing side, users want to reduce their exposure to volatility and take leveraged short positions. Here, we present Euler: a permissionless lending protocol custom-built with an array of new features to help users lend and borrow more types of tokens than ever before.

Euler

Euler (EUL) is experiencing significant bullish momentum, leading to active community discussions around potential breakouts and new all-time highs. Traders are closely watching technical indicators and Fibonacci levels for its next rally, as many view it as a "sleeping giant" in the DeFi borrow/lend space poised for a substantial rebound after past challenges.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

iShares Bitcoin ETF is a focal point of market discussion following recent Bitcoin volatility, with community sentiment sharply divided. While some anticipate a rebound driven by sustained institutional interest and broader ETF accessibility, others caution about an impending 'crypto winter' influenced by historical Bitcoin cycles and macroeconomic shifts.

Rio Tinto Plc engages in the exploration, mining, and processing of mineral resources. It operates through the following business segments: Iron Ore, Aluminium, Copper, and Minerals. The Iron Ore segment supplies iron ore mining and salt and gypsum production. The Aluminium segment produces bauxite, alumina and primary aluminum. The Copper segment offers gold, silver, molybdenum and other by-products. The Minerals includes businesses with products such as uranium, borates, salt and titanium dioxide feedstock together with coal operations. The Other Operations segment covers the curtailed Gove alumina refinery and Rio Tinto Marine operations. The company was founded in 1873 and is headquartered in London, the United Kingdom.

Rio Tinto plc - ADR

Rio Tinto plc

Rio Tinto is trending due to speculative reports of a potential merger with Glencore, which could reshape the global mining landscape. This comes as the company advances its critical minerals strategy through innovations like its Nuton copper technology and strategic lithium plays, fueling widespread discussion on its valuation and future in the evolving energy transition.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending due to intense anticipation and ongoing debate surrounding an imminent joint press release announcing a strategic partnership, widely speculated to involve a major military contractor for government AI solutions. Bulls anticipate a significant rally and short squeeze, citing strong fundamentals and the booming AI data training sector, while skeptics express frustration over potential delays and question the news's impact amid past unfulfilled predictions.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is trending following the FDA's full approval of its lung cancer treatment, IMDELLTRA, and positive trial results for its cholesterol drug, Repatha, which is also seeing a new direct-to-consumer pricing strategy. While community discussion includes mixed efficacy and tolerability data from its obesity drug MariTide, the company's diversified pipeline and strong financial position continue to draw significant investor attention amid broader biotech sector interest and M&A speculation.

Aster is a next-generation decentralized perpetual exchange that combines non-custodial trading with advanced features like hidden orders and multi-chain support. The platform emerged from the merger of Astherus and APX Finance in late 2024, with APX token holders able to migrate their holdings to ASTER.  Aster addresses the gap between centralized and decentralized exchanges by enabling traders to maintain full control of their assets while accessing deep liquidity and CEX-grade trading tools. The platform supports trading of both cryptocurrency perpetuals and U.S. stocks with up to 100x leverage, all settled on-chain in crypto without requiring traditional financial infrastructure.  The platform offers two distinct trading modes to accommodate different user needs. Simple Mode provides one-click, MEV-resistant trading with up to 1001x leverage for beginners, while Pro Mode delivers a full order book with advanced features like automated grid trading and hidden orders that remain invisible until execution.   Aster operates across BNB Chain, Ethereum, Solana, and Arbitrum without requiring bridging, with liquidity pooled across markets to support large trades with minimal slippage. A distinctive feature allows users to deposit yield-generating assets like asBNB or USDF as collateral, earning passive returns while trading, maximizing capital efficiency compared to platforms where collateral sits idle.  Aster received backing from YZi Labs (formerly Binance Labs), which holds a minority stake through a private fund managing over $10 billion on behalf of early Binance executives. Changpeng Zhao, founder of Binance, serves in an advisory role and has personally invested over $2.5 million worth of ASTER tokens.   The ASTER token serves multiple functions including governance rights, staking rewards through liquidity provision, and earning incentives through the platform's points program for traders and liquidity providers.

ASTERION

ASTER is currently a hot topic, primarily driven by strong public endorsement and reported personal investment from Binance founder CZ, igniting speculation about its future. The community is sharply divided; many believe it could be the next major perpetual decentralized exchange or a "BNB on steroids," citing its robust tokenomics and upcoming Layer-1 blockchain. Conversely, a significant portion of the conversation revolves around accusations of market manipulation by CZ, fueling volatile trading and a clear split in investor sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ANI Pharmaceuticals (NASDAQ:ANIP) SVP Sells $133,652.80 in Stock

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) SVP Krista Davis sold 1,622 shares of ANI Pharmaceuticals stock in a transaction that occurred on Thursday, December 18th. The stock was sold...

Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates

VTRS scores four regulatory wins in 2025, from FDA approval of a generic Sandostatin LAR to NDA and IND clearances across its pipeline.

MRNA to Get CEPI Funding for Phase III Study on Pandemic Influenza Jab

Moderna secures up to $54.3 million from CEPI to fund a pivotal phase III study of its mRNA-based H5 pandemic flu vaccine candidate, mRNA-1018.

Squarepoint Ops LLC Takes $2.14 Million Position in ANI Pharmaceuticals, Inc. $ANIP

Squarepoint Ops LLC purchased a new stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The...

SNY's Rare Disease Drug Efdoralprin Alfa Gets EMA's Orphan Drug Tag

Sanofi gains EMA Orphan Drug status for efdoralprin alfa, a phase II biologic for AATD-related emphysema with promising dosing data.

INSM Stock Plummets on Sinus Study Failure, Adds New Pipeline Asset

Insmed sinks nearly 20% after Brinsupri failed a phase IIb sinus study, while the company adds a new monoclonal antibody asset to expand its pipeline.

Zacks Industry Outlook Arcutis, Amicus and ANI 

 Arcutis, Amicus and ANI have been highlighted in this Industry Outlook article.


5 Biotech Stocks to Watch for Potential Upside

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position ARQT, FOLD, ANIP, TNGX and PCRX in this volatile sector. 

GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment

GSK secures FDA approval for Exdensur, the first twice-yearly biologic for treating severe asthma with an eosinophilic phenotype.

RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know

Rezolute shares collapse 79% so far in December after a phase III hyperinsulinism study of its only pipeline candidate miss primary and key secondary endpoints.

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

ANIP
ANI Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANIP News

ANIPANI Pharmaceuticals Inc